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to generate a large pool of pro-T3 cells for initiation of³The Walter and Eliza Hall Institute
TCRb gene rearrangement. Expression of rag-1 andof Medical Research
rag-2 genes, which encode essential components ofPO Royal Melbourne Hospital
the rearrangement machinery, is first induced at theVic 3050
pro-T2 → pro-T3 transition (Godfrey and Zlotnik, 1993).Australia
Expression of the pre-TCR complex (Groettrup et al.,
1993) is necessary and sufficient for sustained survival,
proliferative expansion, and progression of T cell pro-
Summary genitors via the pro-T4 stage into CD41CD81 cortical
thymocytes (Mombaerts et al., 1992a, 1992b; Shinkai et
Signals from cytokine and antigen receptors play cru- al., 1992; Fehling et al., 1995) (Figure 1). These pre-T
cial roles during lymphocyte development. Mice lack- cells undergo TCRa gene rearrangement (Petrie et al.,
ing interleukin-7 receptor are lymphopenic, due to a 1993) and become subject to immunological selection
defect in cell expansion at an early stage of differentia- based on their TCRa/b specificity (von Boehmer, 1994)
tion, and the few mature T cells that develop in IL-7R2/2 (Figure 1).
animals are functionally impaired. Both defects were Interleukin-7 (IL-7) was originally identified and cloned
rescued completely by overexpression of the anti- as a cytokine that induced proliferation of B cell progeni-
apoptosis protein Bcl-2. T cell progenitors lacking an- tors in the absence of stromal cells (Namen et al., 1988;
tigen receptor molecules arealso blocked in differenti- Goodwin et al., 1989). Studies in mice injected with IL-7
ation and die, presumably because they fail to receive or expressing an IL-7 transgene and experiments with
a positive signal via their pre-T cell receptor. Surpris- IL-7-stimulated lymphocytes in tissue culture revealed
ingly, Bcl-2 did not promote survival or differentiation that the cytokine promotes growth and survival of pro-B
of T cells in rag-12/2 mice. These results provide evi- cells, pro-T cells and antigen-stimulated mature T cells
(Murray et al., 1989; Morrissey et al., 1989, 1991; Samar-dence that blocking apoptosis is the essential function
idis et al., 1991; Rich et al., 1993; Fisher et al., 1995).of IL-7R during differentiation and activation of T lym-
IL-7 stimulates cells through a high affinity receptorphocytes and that pre-TCR signaling blocks apathway
complex composed of (at least) the IL-7R and the IL-to apoptosis that is insensitive to Bcl-2.
2R g chain, which is shared between the receptors for
IL-2, IL-4, IL-7, IL-9, and IL-15 (Noguchi et al., 1993;
Introduction Kondo et al., 1994). Injection of mice with neutralizing
antibodies to IL-7 or IL-7R led to a rapid decline of the
The magnitude of hematopoietic cell production is de- short-lived B and T cell progenitors, followed by a slower
termined by the rates of cell division, cell death, and disappearance of the long-lived, mature lymphocytes
cell differentiation (Metcalf, 1989; Raff, 1996). Signals (Grabstein et al., 1993; Sudo et al., 1993). Genetically
from cytokine receptors and antigen receptor molecules modified animals deficient in IL-7 or IL-7R (IL-72/2 mice
are known to be critical for development and function or IL-7R2/2 mice) are severely lymphopenic, but the
of hematopoietic and lymphoid cells (Metcalf, 1989; block in differentiation is not complete and some mature
Godfrey and Zlotnik, 1993; Rajewsky, 1996). For many B and T cells are found in peripheral lymphoid organs
developmental processes that are regulated by these (Peschon et al., 1994; von Freeden-Jeffry et al., 1995).
receptors, it is unclear which of their functions is the The mature T lymphocytes from IL-7R2/2 mice have
essential one: inducing cell division, promoting differen- been shown to be relatively unresponsive to mitogenic
tiation, or inhibiting apoptosis. and antigenic activation (Maraskovsky et al., 1996), con-
Differentiation of T lymphocytes of the TCRa/b lineage sistent with the aforementioned reports that showed
is initiated in the thymus from fetal liver± or bone mar- that IL-7R signaling promotes proliferation and antago-
row±derived hematopoietic stem cells, and CD32CD4lo nizes apoptosis in mature T cells (Morrissey et al., 1989,
CD82Thy-1(CD90)1 thymocytes have been identified as 1991; Murray et al., 1989; Samaridis et al., 1991; Rich
the earliest recognizable T cell progenitors (Shortman et al., 1993). This has established a nonredundant re-
and Wu, 1996) (Figure 1). These cells progressively lose quirement for this receptor/ligand pair in the expansion
their multipotentiality and become committed to the T of B and T cell progenitors, but it still remains unresolved
lineage after acquiring the CD32CD42CD82 (here called whether its essential role is triggering cell division, pro-
pro-T) phenotype. Pro-T cells can be subdivided into moting differentiation, or preventing apoptosis.
four subpopulations according to expression of the cell Pre-TCR signaling is implicated in regulating prolifera-
tion, survival, and differentiation of T lymphocytes at thesurface markers CD25 (IL-2 receptor a chain) and CD44
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Figure 1. Current Model of the Development
of TCRa/b T cells in the Thymus Indicating
the Physiological Pathways to Apoptosis and
Whether or Not They Can Be Inhibited by
Bcl-2
Bcl-2 inhibits apoptosis caused by the ab-
sence of signals from IL-7R (this paper) or
from MHC molecules (no positive selection)
(Linette et al., 1994; Strasser et al., 1994b) but
is a poor antagonist of the deletion of cells
lacking TCR molecules (this paper) or bearing
autoreactive receptors (Sentman et al., 1991;
Strasser et al., 1991; Strasser et al., 1994b).
Large circles represent cycling cells, small
circles quiescent, noncycling cells.
transition from the pro-T3 stage to the pro-T4 stage. constitutively at high levels in T and B lymphoid cells.
The cellularity of thymus and spleen was measured forThe pre-TCR complex is composed of the TCRb chain,
the gp33 pTa chain (which acts as a surrogate TCRa wild-type mice (IL-7R1/1), bcl-2 transgenic mice, mutant
IL-7R2/2 mice, and bcl-2/IL-7R2/2 mice (Figure 2). Con-chain), and the CD3 proteins (Groettrup et al., 1993).
Mice lacking either one of these components of the pre- sistent with our previous observations (Peschon et al.,
1994), IL-7R2/2 mice could be divided into two sub-TCR complex have a severe block in T lymphopoiesis
at the pro-T3 → pro-T4 transition (Mombaerts et al., groups: those (representing about 65% of animals) that
have a thymus cellularity of ,1% of that of wild-type1992a, 1992b; Shinkai et al., 1992; Fehling et al., 1995).
This block is absolute in rag2/2 animals, lacking TCR mice (hereafter called IL-7R2/2 ,1%) and those (z35%)
that have a thymus cellularity of .1% of normal controlschains altogether (Mombaerts et al., 1992a; Shinkai et
al., 1992), but leaky in pTa2/2 mice (Fehling et al., 1995) (hereafter called IL-7R2/2 .1%). Compared to wild-type
mice or bcl-2 transgenic mice, all IL-7R2/2 mice con-and TCRb2/2 mice (Mombaerts et al., 1992b), possibly
because complexes of other TCR chains can partially tained considerably fewer T lymphoid cells in thymus
(13- to 2000-fold reduction) and spleen (5- to 20-foldreplace the function of the classical pre-TCR. As for
the IL-7R, the relative contributions of signals for cell
division, cell differentiation, or cell survival to the overall
function of the pre-TCR remains obscure.
The protein product of the proto-oncogene bcl-2 can
protect cells against a broad range of physiological or
experimentally applied apoptotic stimuli, implying that
multiple signaling routes converge upon a common cell
death effector mechanism that is subject to inhibition
by Bcl-2 (reviewed by Cory, 1995; Korsmeyer, 1995). To
assess the contribution of inhibition of apoptosis to the
overall functions of the IL-7R and the pre-TCR, we intro-
duced a bcl-2 transgene into IL-7R2/2 mice and rag-12/2
mice. The results revealed that Bcl-2 overexpression
could completely rescue T cell development and T cell
function in IL-7R2/2 mice but had no discernible impact
on the production or survival of T cell progenitors in rag-
12/2 mice. These findings have implications for signal
transduction from cytokine receptors and antigen re-
ceptor molecules, for lymphopoiesis, and for the control
of lymphocyte apoptosis.
Results
Expression of a bcl-2 Transgene Rescues
T Lymphocyte Development Figure 2. Expression of a bcl-2 Transgene Rescues T Lymphocyte
in IL-7R-Deficient Mice Production in IL-7R2/2 Mice
The defects in T cell development in IL-7R-deficient Hemocytometric counts were performed on single cell suspensions
prepared from thymus and spleen of wild-type mice, bcl-2mice could be a consequence of reduced cell prolifera-
transgenic mice, IL-7R2/2 mice (with thymus cellularity of ,1% ortion, blocked differentiation, impaired cell survival, or a
.1% of those of wild-type mice), and bcl-2/IL-7R2/2 mice. The num-combination thereof. To determine whether an inhibitor
ber of CD41 and CD81 T cells in the spleen was calculated byof apoptosis could rescue the defect caused by absence
determining their frequency by immunofluorescence staining and
of IL-7R signaling, IL-7R2/2 mice (Peschon et al., 1994) flow cytometric analysis, and multiplication by the total number of
were crossed with Em-bcl-2-36 transgenic mice (Stras- spleen leukocytes. The data represent the arithmetic mean 6 SD
of 9 mice of each type.ser et al., 1991). The latter express a human bcl-2 cDNA
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reduction). In contrast, essentially all bcl-2/IL-7R2/2 CD32CD42CD82 pro-T cells, using antibodies to CD25
(IL-2R a chain) and CD44, confirmed that the numbersmice had normal numbers of thymocytes and splenic T
cells (Figure 2). of pro-T2, pro-T3, and pro-T4 cells are reduced in IL-
7R2/2 mice but are at normal levels in bcl-2/IL-7R2/2The firstobvious abnormality that occurs during differ-
entiation of IL-7R2/2 T cells is a severe reduction in the mice (data not shown). These results demonstrate that
expression of the cell death inhibitor Bcl-2 rescues T cellnumber of CD251 CD32CD42CD82 pro-T cells (Peschon
et al., 1994). Since up to 12 cell divisions are thought to development in IL-7R-deficient mutant mice, indicating
that in this process IL-7R signaling is essential foroccur between this stage and the numerically dominant
population in the thymus, the CD41CD81 pre-T cells, it blocking apoptosis but is not required for proliferation
or differentiation.is conceivable that T lymphopenia is a direct conse-
quence of this defect. To determine whether overex-
pression of Bcl-2 could prevent this early block in T cell Expression of a bcl-2 Transgene Rescues
the Functional Defect of Antigen- ordevelopment in the IL-7R2/2 mice, we investigated the
composition of T cell progenitor populations in bcl-2/ Mitogen-Stimulated IL-7R2/2
T LymphocytesIL-7R2/2 mice. Not only did bcl-2/IL-7R2/2 thymi show
relatively normal cellularity (Figure 2), they also dis- IL-7R deficiency does not cause a complete block in T
cell differentiation, and a numerically reduced (5- to 20-played a normal distribution of the four major subsets:
CD42CD82 progenitors, CD41CD81 precursors, and fold) population of CD41 and CD81 T cells is present in
peripheral lymphoid organs of IL-7R2/2 mice (PeschonCD41CD82 and CD42CD81 mature T cells (Figure 3).
An apparently normal distribution of subsets was noted et al., 1994). These T cells appear phenotypically normal
but are impaired in their responsiveness to mitogenicin those IL-7R2/2 thymus glands with a cellularity of .1%
of that of wild-type mice, although the absolute numbers or antigenic stimulation (Maraskovsky et al., 1996). It is
unclear whether this defect is caused by reduced cellof these cell populations were still reduced by a factor of
10- to 100-fold (Figures 2 and 3). IL-7R2/2 thymi with a division or by excessive apoptosis. Alternatively, IL-7R
functions during development in the thymus are neededcellularity of ,1% of that of wild-type mice were com-
posed almost entirely but not exclusively of immature for expression of an immunological function at the ma-
ture stage (Maraskovsky et al., 1996). We examined theCD32CD42CD82 progenitors (Figure 3). Consistent with
previous observations (Peschon et al., 1994), detailed impact of bcl-2 transgene expression on mitogen- or
antigen-stimulated proliferation and functional matura-analysis of CD42CD82 thymocytes revealed that all IL-
7R2/2 mice (both ,1% and .1%) had a substantial defi- tion of IL-7R2/2 T cells.
Upon stimulation by antibody-mediated cross-linkingcit (50- to 1000-fold in absolute numbers, compared to
wild-type mice) of CD251 pro-T2 and pro-T3 cells (Figure of the TCR/CD3 complex, CD18 (LFA-1 b chain), and
either CD4 or CD8 coreceptors, T cells from IL-7R2/23). In contrast, bcl-2/IL-7R2/2 mice contained relatively
normal numbers of CD251 pro-T2 and pro-T3 cells (Fig- mice yielded 4- to 10-fold fewer lymphoblasts in com-
parison to T cells from normal mice or bcl-2 transgenicure 3). Four-color immunofluorescence analysis of
Figure 3. Expression of a bcl-2 Transgene Rescues T Lymphocyte Differentiation in the Thymus of IL-7R2/2 Mice
Composition of thymocyte subsets was analyzed in wild-type mice, IL-7R2/2 mice (cellularity ,1% of wild-type mice), IL-7R2/2 mice (cellu-
larity .1% of wild-type mice), bcl-2 transgenic mice and bcl-2/IL-7R2/2 mice by immunofluorescence staining and flow cytometric analysis.
The top row presents two-color immunofluorescence contour plots of the expression of CD4 (FITC) and CD8 (R-PE) on all thymocytes. The
bottom row presents a histogram analysis of the expression of CD25/IL-2R a chain (APC) on CD42CD82 thymocytes. The results shown are
representative of data from 9 or more mice of each type.
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Figure 5. Expression of a bcl-2 Transgene Rescues Proliferation of
Antigen-Stimulated T Lymphocytes in IL-7R2/2 Mice
Purified CD41 T cells from the spleen of wild-type mice, IL-7R2/2
mice (cellularity ,1% of wild-type mice), bcl-2 transgenic mice and
bcl-2/IL-7R2/2 mice were activated in vitro with irradiated allogeneic
spleen cells from DBA/2 mice. Cultured cells were pulsed for 6 hr
with 0.5 mCi 3H-thymidine onday 4. The data represent the arithmetic
mean 6 SD of 9 mice from each group.
blockingapoptosis of antigenicallystimulated T lympho-
Figure 4. Expression of a bcl-2 Transgene Rescues Proliferation of cytes and does so through a mechanism that can be
Mitogen-Stimulated T Lymphocytes in IL-7R2/2 Mice replaced by expression of a bcl-2 transgene.
Purified CD41 (5 3 104) and CD81 (1 3 104) spleen cells from wild-
type mice, IL-7R2/2 mice (cellularity ,1% of wild-type mice), IL-
7R2/2 mice (cellularity .1% of wild-type mice), bcl-2 transgenic Expression of a bcl-2 Transgene Does Not Affectmice, and bcl-2/IL-7R2/2 mice were activated in vitro in the presence
T Cell Development in Mutant rag-12/2 Miceof rhIL-2 with immobilized antibodies to CD3, CD18 (LFA-1 b chain),
T cell differentiation is arrested at the pro-T3 stage inand either CD4 or CD8, or with PMA and ionomycin. Total numbers
of viable T cells were determined by hemocytometric counting on mutant rag-12/2 mice that aredefective in antigen recep-
day 6. The data represent the mean 6 SD of 9 mice from each tor gene rearrangement (Godfrey et al., 1992; Mom-
group. baerts et al., 1992b). The lifespan of pro-T3 cells is lim-
ited to approximately 3±4 days in the absence of
productive TCRb gene rearrangement, and such cellsmice (Figure 4). In contrast, CD41 and CD81 T cells from
bcl-2/IL-7R2/2 mice expanded normally in numbers in die, presumably because they fail to receive a positive
signal through the pre-TCR (Penit et al., 1995). As aresponse to this treatment (Figure 4). Similar results
were obtained when purified T lymphocytes were in- consequence, rag-12/2 mice contain normal numbers
of pro-T1, pro-T2, and pro-T3 cellsbut are devoid of pro-stead polyclonallyactivated with phorbol ester and iono-
mycin (Figure 4). T4 cells, CD41CD81 cortical thymocytes, and mature T
cells. Expression of a bcl-2 transgene had little impactTo assess responsiveness to antigenic stimulation,
graded numbers of purified CD41 T cells from mice of on T cell development in rag-12/2 mice. Thymus cellu-
larity was not significantly increased (3±7 3 106 cells asthe various genotypes were activated in cocultures with
irradiated allogeneic DBA/2 spleen cells (Figure 5). Un- in control rag-12/2 mice) and differentiation remained
arrested at the pro-T3 T cell progenitor stage (Figure 6).like IL-7R2/2 T cells that were 10-fold less responsive
to alloantigen, bcl-2/IL-7R2/2 T cells proliferated simi- To investigate the impact of Bcl-2 on production and
death of T cell progenitors, we measured the distributionlarly to wild-type or bcl-2 transgenic T cells (Figure 5).
We wished to determine whether the relatively normal within the cell cycle (Figure 6) and the rate of BrdU
incorporation (Figure 7) of pro-T cells in bcl-2/rag-12/2responsiveness of bcl-2/IL-7R2/2 T cells in vitro re-
flected normal immunoreactivity to antigenic challenge mice and their transgene-negative littermates.
T cell progenitors from mutant rag-12/2 mice, likein vivo. Mice from the different strains were therefore
challenged with P815 allogeneic mastocytoma cells, those from normal animals (Penit et al., 1995), had a
high turnover rate; almost 60% were labeled with BrdUand tumor growth was monitored. All wild-type mice
and bcl-2 transgenic mice rejected P815 tumor cells after two days, and around 90% by day 4 (Figure 7). The
frequency of BrdU-positive Thy-11 thymocytes in bcl-within three weeks of challenge, whereas most (.80%)
IL-7R2/2 mice were unable to do so and had to be sacri- 2/rag-12/2 mice did not differ significantly from that of
rag-12/2 controls (Figure 7). Consistent with these data,ficed. In contrast, all bcl-2/IL-7R2/2 mice were able to
efficiently reject allogeneic tumor transplants. bcl-2 transgene expression did not alter the distribution
within the cell cycle of pro-T1, pro-T2, or pro-T3 cellsThese results reveal that expression of the cell death
inhibitor Bcl-2 rescues the proliferative and functional in rag-12/2 mice (Figure 6).
These results show that overexpression of Bcl-2 can-defect of IL-7R-deficient T cells, thereby restoring nor-
mal T lymphocyte±mediated immunity. It therefore ap- not promote survival of T cellprogenitors that have failed
to undergo productive TCRb gene rearrangement. Thispears that IL-7R signaling plays an essential role in
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Figure 6. Expression of a bcl-2 Transgene
Does Not Alter T Cell Development in rag-1-
Deficient Mice
Pro-T1 (CD252CD441), pro-T2 (CD251CD441),
andpro-T3 (CD251CD44low) cells from the thy-
mus of rag-12/2 and bcl-2/rag-12/2 mice were
purified by FACS, permeabilized, and stained
for flow cytometric analysis of DNA content.
The top row shows two-color immunofluores-
cence dot plots of the expression of CD25
and CD44 on thymic T cells gated for expres-
sion of Thy-1. The bottom two panels show
the DNA content of the purified T cellprogeni-
tors. The percentage of cells with a DNA con-
tent .2C is indicated. The data shown are
representative of those from 4 mice of each
genotype.
physiological cell death must therefore be activated by death (Figures 6 and 7). A fundamental difference there-
fore exists in the developmental potential of pro-T cellsa signaling cascade that is insensitive to Bcl-2.
in bcl-2/IL-7R2/2 mice compared to those from bcl-2/
rag-12/2 mice. This indicates that stimulation of IL-7RDiscussion
and pre-TCR must initiate distinct sets of signaling cas-
cades for regulation of apoptosis, proliferation, and dif-T cell differentiation proceeds through a succession of
ferentiation.genotypically and phenotypically identifiable stages and
is regulated by the interaction of several processes (von
Boehmer, 1994). These include cell expansion prior to Implications for Signal Transduction
from Cytokine Receptorsinitiation of antigen receptor gene rearrangement (Penit
et al., 1995; Shortman and Wu, 1996), proliferation of Our studies on bcl-2/IL-7R2/2 mice indicate that the
essential effects of IL-7R signaling for T cell develop-clones with productive TCRb gene rearrangements
(Godfrey and Zlotnik, 1993), growth arrest during TCRa ment and activation can be replaced by overexpression
of the anti-apoptosis protein Bcl-2 (Figures 2±5). Sincegene rearrangement (Petrie et al., 1993), apoptosis of
cells lacking TCR chains or bearing TCRa/b complexes Bcl-2 does not promote proliferation (in fact, it can slow
it under certain circumstances) (Linette et al., 1996; Ma-that have insufficient affinity for major histocompatibility
complex (MHC) molecules (von Boehmer, 1994), dele- zel et al., 1996; O'Reilly et al., 1996), and since Bcl-2 does
not facilitate differentiation of thymocytes that failed totion of thymocytes bearing autoreactive TCR (Nossal,
1994), and positive selection of cells with potentially receive signals from MHC molecules (Linette et al., 1994;
Strasser et al., 1994b), it appears that the essential func-useful antigen receptor specificities into the pool of
long-lived, mature, recirculating T lymphocytes (von tion of IL-7R signaling in T cell development must be to
promote cell survival. Consistent with this conclusion,Boehmer, 1994). The IL-7R and TCR chains play crucial
roles in the regulation of these processes, but it is un- it has been shown that expression of a bcl-2 transgene
can substitute for IL-7R-transduced survival signals inclear whether it is their effect on cell division, cell survival
or differentiation, or a combination thereof that is re- pre-B cell lines growing on stromal layers (Rolink et al.,
1993). Other studies did, however, indicate that IL-7Rsponsible for their activity. We wanted to dissect these
processes to see whether differentiation and prolifera- signaling is needed not only for inhibiting apoptosis but
also for proliferation (Namen et al., 1988; Goodwin ettion require active signaling via IL-7R or TCR chain±
containing surface receptors or is merely a conse- al., 1989; Murrayet al., 1989) and differentiation (Muegge
et al., 1993) of lymphoid cells. What might be the expla-quence of sustained T cell survival. This was achieved
by constructing novel strains of mice bearing either mu- nation for this apparent discrepancy? In the tissue cul-
ture experiments that demonstrated a proliferative ef-tations in the IL-7R or mutations that block antigen re-
ceptor gene rearrangement (rag-12/2) and expressing in fect of IL-7, other growth stimuli, such as antigen
receptor cross-linking or signals from stromal cells, weretheir T cells a bcl-2 transgene to inhibit apoptosis. We
found that overexpression of Bcl-2 was sufficient to usually present (Morrissey et al., 1989; Murray et al.,
1989) or cell growth was short-term and was initiatedrescue T cell development (Figures 2 and 3) and T cell
function (Figures 4 and 5) in IL-7R-deficient mice but by cells that were cycling in vivo at the time of isolation
(Namen et al., 1988; Goodwin et al., 1989). The experi-could not rescue rag-12/2 pro-T cells, which are unable
to express pre-TCR molecules, from programmed cell ments that implicated signals from IL-7R as an initiating
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function by inducing expression of Bcl-2 or one of its
homologs. Consistent with this idea, Bcl-2 and IL-7R
are coexpressed at high levels in CD32CD42CD82 pro-T
cells and mature T lymphocytes and absent from
CD41CD81 pre T cells (Sudo et al., 1993; Veis et al.,
1993). We are currently investigating whether loss of
IL-7R leads to reduced levels of Bcl-2 in pro-T cells.
Alternatively, IL-7R signaling could promote cell survival
at a step upstream of the cell death effector machinery
by interfering with a default pathway to apoptosis that
is normally activated in situations of limiting supply of
growth factors.
Implications for Signal Transduction
from the Pre-T Cell Receptor
Our analysis of bcl-2/rag-12/2 mice shows that Bcl-2
overexpression has no discernible effect on the block
to T cell development caused by the absence of TCR
molecules (Figures 6 and 7). This is consistent with previ-
ous observations that expression of a bcl-2 transgene
does not significantly increase thymus cellularity in mu-
tant scid or rag-22/2 mice (Linette et al., 1994; Strasser
et al., 1994a). Neither of these two studies, however,
investigated the effect of Bcl-2 on the pro-T3 → pro-T4
differentiation step or on the in vivo lifespan of pro-T
cells. Our detailed analysis of cell surface markers (Fig-
ure 6) and cell turnover (Figure 7) established that Bcl-2
is unable to promote survival or differentiation of pro-T
cells lacking signals from the pre-TCR. It is unlikely thatFigure 7. Expression of a bcl-2 Transgene Does Not Affect the Turn-
over Rate of Pro-T Cells in rag-1-Deficient Mice the lack of an effect of Bcl-2 is due to insufficient levels
of transgene expression at the pro-T stage, since it isCohorts of rag-12/2 and bcl-2/rag-12/2 mice were fed continuously
for 1, 2, or 4 days with BrdU to label proliferating cells. Thymocytes capable of rescuing those cells from lack of IL-7R signal-
were stained with monoclonal antibodies specific to Thy-1 (y axis: ing (Figures 2 and 3) and since it prolongs the survival
Tricolor) and BrdU (x axis: FITC) to determine the percentage of T of purified scid and rag-12/2 pro-T cells in tissue culture
lymphocytes that had incorporated BrdU. The top panels show re-
(data not shown).sults of 4 days of continuous BrdU labeling as two-color dot plots
What signaling cascades might be responsible for(A) and histograms of the BrdU labeling profile of Thy-11 T cells (B).
pre-TCR induced survival, proliferation, and differentia-The bottom panel (C) shows the fraction of BrdU-labeled T cells as
a function of time of continuous labeling. Values are arithmetic tion of cells? The lck tyrosine kinase is a likely candidate
means 6 SD from 2 mice of each genotype at each time point. for signal transduction, since lck2/2 mice (Mollina et al.,
1992) have a phenotype similar to that of pTa2/2 mice
(Fehling et al., 1995). The structure of the pre-TCR com-event for TCR gene rearrangement were performed on
plex is similar to that of the TCRa/b complex; by analogythymocytes in tissue culture (Muegge et al., 1993). Since
to TCRa/b stimulation, it is therefore expected that theIL-7 promotes survival of thymocytes in vitro (Murray et
pre-TCR activates a range of signal transduction path-al., 1989), it is unclear whether IL-7 was directly respon-
ways, such as the ras/MAP kinase pathway and the Rel/sible for initiating rearrangement or merely facilitated it
NF-kB family of transcription factors. These signalingby inhibiting apoptosis. In any case, the finding that
molecules presumably act in concert to regulate pas-some mature lymphocytes are formed in IL-72/2 mice
sage of developing T cells through the pre-TCR check-and IL-7R2/2 mice is inconsistent with the notion of an
point (Godfrey and Zlotnik, 1993).indispensable role for IL-7R signaling in differentiation.
In conclusion, there appears to be no evidence contra-
dictory to thehypothesis that IL-7R signaling promotesT Implications for the Control of T Cell Development
TCR chains are critical regulators of the later stages oflymphocyte growth and developmentsolely by inhibiting
apoptosis. T cell differentiation, at the time when antigen receptor
gene rearrangement occurs (Figure 1). Expression of theWhat signaling cascades might be responsible for IL-
7-induced cell survival? It is likely that the IL-2R g chain pre-TCR is a prerequisite for passage of T lymphoid cells
through the pro-T3 → pro-T4 developmental checkpointand the Jak-3 kinase are critically involved, since mutant
mice lacking these molecules have a phenotype similar and for clonal expansion of thymocytes with productive
TCRb gene rearrangements (Mombaerts et al., 1992a;to that of IL-7R2/2 animals (Cao et al., 1995; Nosaka et
al., 1995). It will therefore be interesting to test whether Fehling et al., 1995) (Figure 1). Differentiation from the
CD41CD81 pre-T cell stage to mature cells (CD41CD82expression of a bcl-2 transgene can also rescue T cell
development and T cell function in IL-2R g chain2/2 mice or CD42CD81) and immunological repertoire selection
are regulated by TCRa/b heterodimers (Mombaerts etand Jak-32/2 mice. The survival signal from IL-7R could
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for 5 or more generations with C57BL/6 mice. The bcl-2/IL-7R2/2al., 1992a; Philpott et al., 1992) (Figure 1). What is the
mice and bcl-2/rag-12/2 mice were generated by crossing Em-bcl-nature of the surface receptors that regulate differentia-
2-36 mice for two or more generations with IL-7R2/2 mice or rag-tion and cell cycling during the early stages of T lympho-
12/2 mice, respectively. Inheritance of the mutated IL-7R allele, the
poiesis prior to antigen receptor gene rearrangement? mutated rag-1 allele, andthe Em-bcl-2-36 transgene was determined
IL-7R appears to be required for cell survival but not by Southern blotting or PCR analysis (Peschon et al., 1994; Spano-
poulou et al., 1994; Strasser et al., 1995). All animals were analyzedneeded for cell cycling and differentiation (Figures 2 and
at 4±8 weeks of age.3). Indeed, it appears that none of the receptors that
utilize the IL-2R g chain (IL-2R, IL-4R, IL-7R, IL-9R, and
Immunofluorescence Staining, Flow CytometricIL-15R) are indispensable for differentiation, since mu-
Analysis, and Cell Sortingtant mice lacking this molecule can produce some ma-
Isolation of CD41 and CD81 T cells from spleen was carried out
ture T cells, albeit at reduced numbers (Cao et al., 1995). as described previously (Maraskovsky et al., 1996). Erythrocyte-
Receptors for other stromal cell±derived factors may be depleted spleen cells (2 3 107) were incubated for 20 min at 48C
with a cocktail of the following monoclonal antibodies: anti-crucial regulators of early T lymphopoiesis, and c-Kit
CD45R(B220), anti-Gr-1, anti-NK1.1, and anti-Mac-1 (Pharmingen).and Flk2/Flt3 are likely candidates, since mice bearing
After washing in PBS±FCS, the cells were incubated for 20 min atmutations in these genes have reduced numbers of pro-
48C with anti-rat Ig-coated magnetic beads (Dynal) in a slurry ofT cells (Mackarehtschian et al., 1995; Rodewald et al., PBS±FCS. The mixture was then diluted in 5 ml PBS±FCS, cells
1995). were coated with antibodies, and beads were removed with a mag-
net (Dynal). The remaining cells were stained with fluorescein iso-
thiocyanate (FITC) anti-CD4 (GK-1.5) and phycoerythrin (R-PE) anti-Implications for the Control
CD8 (53-6.7) for 30 min at 48C in PBS±FCS. To reduce nonspecificof Lymphocyte Apoptosis
binding of antibodies to Fcg receptors, 50 mg/ml of rat monoclonalCell death is a common fate of developing T cells: ap-
antibody 2.4G2 (anti-mouse FcgRII) was included during stainingproximately 97% of all cells generated within the thymus
with fluorochrome-coupled antibodies. Cells were resuspended in
undergo apoptosis in situ (Egerton et al., 1990; Surh and PBS±FCS containing 0.5 mg/ml propidium iodide (Sigma) before
Sprent, 1994). Thymocytes lacking productive TCR gene sorting on a FACStar1 (Becton Dickinson). Dead cells and damaged
cells were excludedon the basis of low anglescatter and red fluores-rearrangements or expressing a TCRa/b with insufficient
cence due to propidium iodide uptake. Routine analysis of sortedavidity for MHC molecules die because they fail to re-
cells for CD4 or CD8 expression revealed a cell population of 96%±ceive a survival signal (ªdeath by neglectº) (Surh and
99% purity. CD32CD42CD82 T cell progenitor subpopulations fromSprent, 1994), while those bearing autoreactive recep-
thymus of rag-12/2 and bcl-2/rag-12/2 mice were purified according
tors are deleted after receiving a signal through the to a published procedure (Godfrey et al., 1992). Thymocytes were
TCRa/b (Murphy et al., 1990). Bcl-2 can inhibit apoptosis stained in the presence of 2% normal rat serum with R-PE-conju-
gated anti-CD25 (Caltag), FITC-conjugated anti-CD44 (IM71), Texasof thymocytes that failed to receive a positive signal
Red- or Cy-5-conjugated anti-Thy-1 (T24.31.2), and propidium io-from MHC (Linette et al., 1994; Strasser et al., 1994b),
dide (PI at 0.5 mg/ml, Sigma). All monoclonal antibodies for whichbut it is a poor antidote to deletion of cells bearing
no commercial source is indicated were purified in our laboratoriesautoreactive receptors (Sentman et al., 1991; Strasser
from hybridoma supernatant on protein G±Sepharose (Pharmacia)
et al., 1991; Strasser et al., 1994b) (Figure 1). Our studies and conjugated with biotin (Pierce), FITC, Texas Red (both from
of bcl-2/IL-7R2/2 mice indicate that deprivation of IL-7 Molecular Probes), or Cy-5 (Amersham) according to each supplier's
instructions. Viable (PI2), CD32CD42CD82Thy-11 T cell progenitorsinduces in pro-T cells ªdeath by neglectº by a mecha-
were sorted into the three subpopulations: CD252CD44hi (pro-T1),nism that can be blocked by Bcl-2. We expected that
CD251CD44hi (pro-T2), and CD251CD44low (pro-T3) using a FACStar1pro-T cells lacking TCR chains also die by an apoptotic
or a modified FACSII (Becton Dickinson) cell sorter. Multiparametermechanism that can be antagonized by Bcl-2, particu-
analysis of fluorescent antibody±stained cells was performed on a
larly since Bcl-2 promotes survival and accumulation of FACScan (Becton Dickinson).
B lymphoid cells that are unable to express immuno-
globulin chains in bcl-2/scid and bcl-2/rag2/2 mice Tissue Culture
Single cell suspensions from thymus, spleen, or lymph nodes were(Strasser et al., 1994a; Young et al., 1997; D. Tarlinton
prepared in phosphate buffered saline (PBS) containing 5% heat-et al., submitted). Our analysis of the development (Fig-
inactivated fetal calf serum (PBS±FCS) and cultured in Dulbecco'sure 6) and turnover (Figure 7) of T cells in bcl-2/rag-12/2
modified Eagle's (DME) medium, supplemented with 216 mg/Lmice demonstrated, however, that absence of pre-TCR
L-glutamine, 50 mM 2-mercaptoethanol, antibiotics, and 10% heat-
signaling triggers a Bcl-2-insensitive pathway to cell inactivated FCS (DMEM±FCS). Erythrocytes were removed by lysis
death. What might the nature of this death signal be? in NH4Cl. The following monoclonal antibodies were used for mito-
genic stimulation of purified T cells in tissue culture: 145-2C11 (ham-Activation of receptors of the tumor necrosis factor re-
ster anti-mouse CD3), GK1.5 (rat anti-mouse CD4), 53-6.7 (rat anti-ceptor family (TNF-R) is a possibility since it has been
mouse CD8), and I21/7.7 (rat anti-mouse LFA-1 b chain/CD18). Allshown that p55 TNF-RI and CD95 (Fas/APO-1) can trig-
antibodies were purified from hybridoma supernatant by chroma-ger apoptosis in some cell types in a manner that is
tography on protein A or protein G columns (Pharmacia). Tissue
insensitive to Bcl-2 (Vanhaesebroeck et al., 1993; culture plates were coated with these antibodies at a concentration
Memon et al., 1995; Strasser et al., 1995). of 10±15 mg/ml in PBS (4 hr at 378C or overnight at48C). Recombinant
human interleukin 2 (rhIL-2) produced in E. coli was purchased from
Cetus Corporation. For low density cultures, 5 3 104 purified CD41Experimental Procedures
or 1 3 104 purified CD81 T cells were cultured in 24-well flat-bottom
culture trays (Falcon) either with immobilized mitogenic antibodiesMice
The IL-7R2/2 mice (Peschon et al., 1994), the rag-12/2 mice (Spano- or with PMA (1 ng/ml) and ionomycin (125 ng/ml; Sigma) in 1 ml of
DMEM±FCS with 30 ng/ml rhIL-2. At various days after initiation ofpoulou et al., 1994), and the Em-bcl-2-36 transgenic strain (Strasser
et al., 1991), expressing a human bcl-2 cDNA constitutively at high culture, cells were harvested and counted in a hemocytometer.
Mixed lymphocyte reactions were performed in 96-well round-bot-levels in B and T lymphocytes, have been described previously.
Prior to these studies, all of these strains had been backcrossed tom trays (Nunc). Graded numbers of purified CD41 splenic T cells
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were cultured with g-irradiated (20 Gy) allogeneic DBA/2 spleen Egerton, M., Shortman, K., and Scollay, R. (1990). The kinetics of
immature thymocyte development in vivo. Int. Immunol. 2, 501±507.cells (1 3 105/well). Cultures were pulsed after 4 days for 6 hr with
0.5 mCi of 3H-thymidine (Amersham). Fehling, H.J., Krotkova, A., Saitnruf, C., and Von Boehmer, H. (1995).
Crucial role of the pre-T-cell receptor alpha gene in development
Cell Turnover Analysis of alpha-beta but not gamma-delta T cells. Nature 375, 795±798.
Cell turnover was measured by labeling proliferating cells in vivo Fisher, A.G., Burdet, C., Bunce, C., Merkenschlager, M., and
with the thymidine analog bromodeoxyuridine (BrdU; Sigma), which Ceredig, R. (1995). Lymphoproliferative disorders in IL-7 transgenic
was provided continuously for 1, 2, or 4 days in the drinking water mice: expansion of immature B cells which retain macrophage po-
(1 mg/ml plus 2% glucose to overcome taste aversion). Drinking tential. Int. Immunol. 7, 415±423.
water bottles were shielded from light and refreshed at three-day
FoÈ rster, I., Vieira, P., and Rajewsky, K. (1989). Flow cytometric analy-intervals. The cellularity of thymus, spleen, bone marrow, and lymph
sis of cell proliferation dynamics in the B cell compartment of thenodes did not alter significantly during the course of this treatment,
mouse. Int. Immunol. 1, 321±331.indicating that it was not toxic, as shown before (FoÈ rster et al., 1989;
Fulcher, D.A., and Basten, A. (1994). Reduced life span of anergicFulcher and Basten, 1994). BrdU incorporated into cellular DNA
self-reactive B cells in a double-transgenic model. J. Exp. Med. 179,was detected by immunofluorescence staining with a specific FITC-
125±134.labeled monoclonal antibody, BU-1 (Becton Dickinson), and flow
Godfrey, D.I., and Zlotnik, A. (1993). Control points in early T-cellcytometric analysis according to published procedures (FoÈ rster et
development. Immunol. Today 14, 547±553.al., 1989; Fulcher and Basten, 1994). Briefly, cells were fixed in 0.5%
paraformaldehyde in PBS (20 min at room temperature). As the BU-1 Godfrey, D.I., Zlotnik, A., and Suda, T. (1992). Phenotypical and
antibody only binds to BrdU in single-stranded DNA, the DNA was functional characterization of c-kit expression during intrathymic T
denatured with 3N HCl containing 0.5% Tween-20 to permeabilize cell development. J. Immunol. 149, 2281±2285.
cell membranes (20 min at room temperature). The acid was neutral- Goodwin, R.G., Lupton, S., Schmierer, A., Hjerrild, K.J., Jerzy, R.,
ized with 0.1 M di-sodium tetraborate, and cells were then stained Clevenger, W., Gillis,S., Cosman, D., andNamen, A.E. (1989). Human
(30 min) with FITC-BU-1 in 0.5% Tween-20. Combined analysis of interleukin 7: molecular cloning and growth factor activity on human
incorporated BrdU and cell surface antigen expression to identify and murine B-lineage cells. Proc. Natl. Acad. Sci. USA 86, 302±306.
T lymphocytes was performed by staining cells with FITC-BU-1
Grabstein, K.H., Waldschmidt, T.J., Finkelman, F.D., Hess, B.W.,
and biotin-labeled anti-Thy-1 (T24.31.2), which was revealed with
Alpert, A.R., Boiani, N.E., Namen, A.E., and Morrissey, P.J. (1993).
Tricolor-streptavidin (Caltag). Flow cytometric analysis (10,000 cells
Inhibition of murineB and T lymphopoiesis in vivo by an anti-interleu-
per sample) was performed on a FACScan (Becton Dickinson) using kin 7 monoclonal antibody. J. Exp. Med. 178, 257±264.
the software provided. As a negative control for the BrdU staining,
Groettrup, M., Ungewiss, K., Azogui, O., Palacios, R., Owen, M.J.,we included thymocytes from a mouse that had not received BrdU
Hayday, A.C., and von Boehmer, H. (1993). A novel disulfide-linkedin all experiments. Routinely, fewer than 2% of such cells were
heterodimer on pre-T cells consists of the T cell receptor b chainstained by FITC-BU-1. As a positive control for both BrdU uptake
and a 33 kd glycoprotein. Cell 75, 283±294.into the animal and for staining with BU-1-FITC, we routinely con-
Kondo, M., Takeshita, T., Higuchi, M., Nakamura, M., Sudo, T., Nishi-firmed that bone marrow granulocytes were strongly labeled.
kawa, S.-I., and Sugamura, K. (1994). Functional participation of
the IL-2 receptor g chain in IL-7 receptor complexes. Science 263,Cell Cycle Analysis
1453±1454.Purified thymocyte subpopulations were analyzed for their distribu-
tion among the phases of the cell cycle by flow cytometry. DNA Korsmeyer, S.J. (1995). Regulators of cell death. Trends Genet. 11,
101±105.was labeled by staining cells for .30 min at 48C with 50 mg/ml PI
in 0.1% sodium acetate, 0.2% Triton X-100 (BDH Chemicals). Flow Linette, G.P., Grusby, M.J., Hedrick, S.M., Hansen, T.H., Glimcher,
cytometric analysis (10,000 cells per sample) was performed on a L.H., and Korsmeyer, S.J. (1994). Bcl-2 is upregulated at the
FACScan (Becton Dickinson) at a low flow rate (100±300 cells/sec). CD41CD81 stage during positive selection and promotes thymocyte
Cell cycle distribution was determined with the FACScan Cellfit differentiation at several control points. Immunity 1, 197±205.
program or by manual gating. Linette, G.P., Li, Y., Roth, K., and Korsmeyer, S.J. (1996). Cross talk
between cell death and cell cycle progression: BCL-2 regulates
Acknowledgments NFAT-mediated activation. Proc. Natl. Acad. Sci. USA 93, 9545±
9552.
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